• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示 SARS-CoV-2 阳性患者上呼吸道微生物群特征。

Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + .

机构信息

Department of Information Engineering, University of Padova, 35131, Padova, Italy.

Department of Molecular Medicine, University of Padova, 35121, Padova, Italy.

出版信息

Sci Rep. 2023 Oct 6;13(1):16867. doi: 10.1038/s41598-023-43040-x.

DOI:10.1038/s41598-023-43040-x
PMID:37803040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10558486/
Abstract

The outbreak of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, forced us to face a pandemic with unprecedented social, economic, and public health consequences. Several nations have launched campaigns to immunize millions of people using various vaccines to prevent infections. Meanwhile, therapeutic approaches and discoveries continuously arise; however, identifying infected patients that are going to experience the more severe outcomes of COVID-19 is still a major need, to focus therapeutic efforts, reducing hospitalization and mitigating drug adverse effects. Microbial communities colonizing the respiratory tract exert significant effects on host immune responses, influencing the susceptibility to infectious agents. Through 16S rDNAseq we characterized the upper airways' microbiota of 192 subjects with nasopharyngeal swab positive for SARS-CoV-2. Patients were divided into groups based on the presence of symptoms, pneumonia severity, and need for oxygen therapy or intubation. Indeed, unlike most of the literature, our study focuses on identifying microbial signatures predictive of disease progression rather than on the probability of infection itself, for which a consensus is lacking. Diversity, differential abundance, and network analysis at different taxonomic levels were synergistically adopted, in a robust bioinformatic pipeline, highlighting novel possible taxa correlated with patients' disease progression to intubation.

摘要

2019 年冠状病毒病(COVID-19)的爆发是由 SARS-CoV-2 引起的,这迫使我们面对一场具有前所未有的社会、经济和公共卫生后果的大流行。许多国家已经开展了疫苗接种运动,为数百万人口接种疫苗以预防感染。与此同时,治疗方法和发现不断涌现;然而,确定哪些感染患者将经历 COVID-19 的更严重后果仍然是一个主要需求,以便集中治疗努力,减少住院治疗并减轻药物不良反应。定植在呼吸道中的微生物群落对宿主免疫反应产生重大影响,影响对感染因子的易感性。通过 16S rDNAseq,我们对 192 名鼻咽拭子检测出 SARS-CoV-2 阳性的患者的上呼吸道微生物群落进行了特征分析。根据症状、肺炎严重程度以及是否需要吸氧或插管,将患者分为不同的组。事实上,与大多数文献不同,我们的研究重点是确定预测疾病进展的微生物特征,而不是感染本身的可能性,因为这方面缺乏共识。在不同的分类学水平上,多样性、差异丰度和网络分析协同采用,在一个稳健的生物信息学管道中,突出了与患者插管进展相关的新型可能分类群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/826476dc5835/41598_2023_43040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/6e7cae1d196f/41598_2023_43040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/1aa4f23a70f8/41598_2023_43040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/f741d8377894/41598_2023_43040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/826476dc5835/41598_2023_43040_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/6e7cae1d196f/41598_2023_43040_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/1aa4f23a70f8/41598_2023_43040_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/f741d8377894/41598_2023_43040_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e6/10558486/826476dc5835/41598_2023_43040_Fig4_HTML.jpg

相似文献

1
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + .揭示 SARS-CoV-2 阳性患者上呼吸道微生物群特征。
Sci Rep. 2023 Oct 6;13(1):16867. doi: 10.1038/s41598-023-43040-x.
2
Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.鼻咽部微生物群中超优势性病原体细菌导致 COVID-19 患者继发细菌性感染。
Microbiol Spectr. 2022 Jun 29;10(3):e0195621. doi: 10.1128/spectrum.01956-21. Epub 2022 May 17.
3
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.COVID-19 严重程度和呼吸道微生物组免疫反应特征。
mBio. 2021 Aug 31;12(4):e0177721. doi: 10.1128/mBio.01777-21. Epub 2021 Aug 17.
4
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.对确诊和疑似 COVID-19 患者的鼻咽拭子标本进行宏基因组下一代测序。
mBio. 2020 Nov 20;11(6):e01969-20. doi: 10.1128/mBio.01969-20.
5
Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.唾液微生物组的多样性、组成和网络可区分 COVID-19 发作的严重程度,这是通过对 16S rRNA 可变区 V1-V3 序列的分析揭示的。
mSystems. 2023 Aug 31;8(4):e0106222. doi: 10.1128/msystems.01062-22. Epub 2023 Jun 13.
6
Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.鼻咽微生物组的改变与 SARS-CoV-2 感染状况和疾病严重程度有关。
PLoS One. 2022 Oct 14;17(10):e0275815. doi: 10.1371/journal.pone.0275815. eCollection 2022.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota.宏基因组分析 RNA 测序数据揭示了 SARS-CoV-2 介导的上呼吸道微生物组进行性失调。
Biomed J. 2021 Aug;44(4):504-507. doi: 10.1016/j.bj.2021.02.008. Epub 2021 Feb 27.
9
Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome.COVID-19 死亡患者上呼吸道转录活跃微生物组中阿氏假单胞菌和蜡样芽孢杆菌丰度增加表明合并感染在疾病严重程度和转归中的作用。
Microbiol Spectr. 2022 Jun 29;10(3):e0231121. doi: 10.1128/spectrum.02311-21. Epub 2022 May 17.
10
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to ?新冠病毒阳性患者鼻咽微生物组特征:我们能明确其作用吗?
Front Cell Infect Microbiol. 2021 Feb 15;11:625581. doi: 10.3389/fcimb.2021.625581. eCollection 2021.

引用本文的文献

1
The Human Nasal Microbiome: A Perspective Study During the SARS-CoV-2 Pandemic in Malta.人类鼻腔微生物群:马耳他新冠疫情期间的一项前瞻性研究
Microorganisms. 2024 Dec 13;12(12):2570. doi: 10.3390/microorganisms12122570.
2
Oropharyngeal Microbiome Analysis in Patients with Varying SARS-CoV-2 Infection Severity: A Prospective Cohort Study.不同严重程度的新型冠状病毒肺炎患者的口咽微生物群分析:一项前瞻性队列研究
J Pers Med. 2024 Mar 29;14(4):369. doi: 10.3390/jpm14040369.

本文引用的文献

1
Nasopharyngeal Dysbiosis Precedes the Development of Lower Respiratory Tract Infections in Young Infants, a Longitudinal Infant Cohort Study.鼻咽微生态失调先于婴幼儿下呼吸道感染的发生:一项纵向婴儿队列研究。
Gates Open Res. 2024 Mar 20;6:48. doi: 10.12688/gatesopenres.13561.2. eCollection 2022.
2
Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance.COVID-19 患者呼吸道微生物组的改变:当前观察结果及潜在意义。
Microbiome. 2022 Oct 5;10(1):165. doi: 10.1186/s40168-022-01342-8.
3
Investigating differential abundance methods in microbiome data: A benchmark study.
探究微生物组数据中的差异丰度方法:基准研究。
PLoS Comput Biol. 2022 Sep 8;18(9):e1010467. doi: 10.1371/journal.pcbi.1010467. eCollection 2022 Sep.
4
Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients.影响新冠患者临床病程的鼻咽微生物群特征
Front Microbiol. 2022 May 17;13:871627. doi: 10.3389/fmicb.2022.871627. eCollection 2022.
5
Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome.COVID-19 死亡患者上呼吸道转录活跃微生物组中阿氏假单胞菌和蜡样芽孢杆菌丰度增加表明合并感染在疾病严重程度和转归中的作用。
Microbiol Spectr. 2022 Jun 29;10(3):e0231121. doi: 10.1128/spectrum.02311-21. Epub 2022 May 17.
6
Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of and in COVID-19 patients: a potential source of co-infection.长读 16S-seq 揭示 COVID-19 患者鼻咽微生物失调和 的富集:合并感染的潜在来源。
Mol Omics. 2022 Jul 11;18(6):490-505. doi: 10.1039/d2mo00044j.
7
Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.严重 COVID-19 与上呼吸道微生物组改变有关。
Front Cell Infect Microbiol. 2022 Jan 24;11:781968. doi: 10.3389/fcimb.2021.781968. eCollection 2021.
8
Microbiome differential abundance methods produce different results across 38 datasets.微生物组差异丰度方法在 38 个数据集上产生了不同的结果。
Nat Commun. 2022 Jan 17;13(1):342. doi: 10.1038/s41467-022-28034-z.
9
Multivariable association discovery in population-scale meta-omics studies.基于人群的宏基因组学研究中的多变量关联发现。
PLoS Comput Biol. 2021 Nov 16;17(11):e1009442. doi: 10.1371/journal.pcbi.1009442. eCollection 2021 Nov.
10
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series.新冠肺炎危重症患者的肠球菌血流感染:病例系列
Ann Med. 2021 Dec;53(1):1779-1786. doi: 10.1080/07853890.2021.1988695.